MEIP MEI PHARMA INC Management Changes 8-K Filing 2023 - Management Changes MEI Pharma, Inc. appointed David M. Urso as President and CEO, terminating the employment of Daniel Gold, as part of a planned transition prior to the merger with Infinity Pharmaceuticals, Inc.Get access to all SEC 8-K filings of the MEI PHARMA INC